308 related articles for article (PubMed ID: 10748654)
1. [Diabetes, coagulation and vascular events].
Nenci GG; Paliani U
Recenti Prog Med; 2000 Feb; 91(2):86-90. PubMed ID: 10748654
[TBL] [Abstract][Full Text] [Related]
2. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
Petersen KR
Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
[TBL] [Abstract][Full Text] [Related]
3. Diabetes mellitus as a prothrombotic condition.
Grant PJ
J Intern Med; 2007 Aug; 262(2):157-72. PubMed ID: 17645584
[TBL] [Abstract][Full Text] [Related]
4. Thromboxane-dependent CD40 ligand release in type 2 diabetes mellitus.
Santilli F; Davì G; Consoli A; Cipollone F; Mezzetti A; Falco A; Taraborelli T; Devangelio E; Ciabattoni G; Basili S; Patrono C
J Am Coll Cardiol; 2006 Jan; 47(2):391-7. PubMed ID: 16412866
[TBL] [Abstract][Full Text] [Related]
5. Impaired endothelial antithrombotic activity following short-term interruption of continuous subcutaneous insulin infusion in type 1 diabetic patients.
Iorio A; Federici MO; Mourvaki E; Ferolla P; Piroddi M; Stabile A; Timi A; Celleno R; Benedetti MM
Thromb Haemost; 2007 Sep; 98(3):635-41. PubMed ID: 17849053
[TBL] [Abstract][Full Text] [Related]
6. In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation.
Davì G; Ciabattoni G; Consoli A; Mezzetti A; Falco A; Santarone S; Pennese E; Vitacolonna E; Bucciarelli T; Costantini F; Capani F; Patrono C
Circulation; 1999 Jan; 99(2):224-9. PubMed ID: 9892587
[TBL] [Abstract][Full Text] [Related]
7. [Lipoprotein (a) and diabetes mellitus].
Ziegler O; Guerci B; Candiloros H; Drouin P
Diabete Metab; 1995 Apr; 21(2):127-38. PubMed ID: 7621973
[TBL] [Abstract][Full Text] [Related]
8. Enhanced lipid peroxidation and platelet activation in the early phase of type 1 diabetes mellitus: role of interleukin-6 and disease duration.
Davì G; Chiarelli F; Santilli F; Pomilio M; Vigneri S; Falco A; Basili S; Ciabattoni G; Patrono C
Circulation; 2003 Jul; 107(25):3199-203. PubMed ID: 12810609
[TBL] [Abstract][Full Text] [Related]
9. [Vascular wall and diabetes mellitus: what complications and why?].
Marre M
Therapie; 1997; 52(5):371-4. PubMed ID: 9501559
[TBL] [Abstract][Full Text] [Related]
10. Aging and plasminogen activator inhibitor-1 (PAI-1) regulation: implication in the pathogenesis of thrombotic disorders in the elderly.
Yamamoto K; Takeshita K; Kojima T; Takamatsu J; Saito H
Cardiovasc Res; 2005 May; 66(2):276-85. PubMed ID: 15820196
[TBL] [Abstract][Full Text] [Related]
11. Hyperglycaemic siblings of Type II (non-insulin-dependent) diabetic patients have increased PAI-1, central obesity and insulin resistance compared with their paired normoglycaemic sibling.
Herlihy OM; Barrow BA; Grant PJ; Levy JC
Diabetologia; 2002 May; 45(5):635-41. PubMed ID: 12107743
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular risk factors in type 2 diabetes: the role of hyperglycaemia.
Massi-Benedetti M; Federici MO
Exp Clin Endocrinol Diabetes; 1999; 107 Suppl 4():S120-3. PubMed ID: 10522835
[TBL] [Abstract][Full Text] [Related]
13. Influence of metabolic control on thromboxane biosynthesis and plasma plasminogen activator inhibitor type-1 in non-insulin-dependent diabetes mellitus.
Davì G; Belvedere M; Vigneri S; Catalano I; Giammarresi C; Roccaforte S; Consoli A; Mezzetti A
Thromb Haemost; 1996 Jul; 76(1):34-7. PubMed ID: 8819248
[TBL] [Abstract][Full Text] [Related]
14. Plasminogen activator inhibitor-1: a common denominator in obesity, diabetes and cardiovascular disease.
De Taeye B; Smith LH; Vaughan DE
Curr Opin Pharmacol; 2005 Apr; 5(2):149-54. PubMed ID: 15780823
[TBL] [Abstract][Full Text] [Related]
15. Diabetic microangiopathy: lupus anticoagulant dependent thrombotic tendency in type 1 (insulin-dependent) diabetes mellitus.
Gargiulo P; Schiaffini R; Bosco D; Ciampalini P; Pantaleo A; Romani B; Arcieri P; Andreani D
Diabet Med; 1997 Feb; 14(2):132-7. PubMed ID: 9047090
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of fibrinolysis in poorly controlled, hospitalized type 2 diabetic patients by short-term metabolic control: association with a decrease in plasminogen activator inhibitor 1.
Aso Y; Okumura KI; Yoshida N; Tayama K; Takemura Y; Inukai T
Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):175-80. PubMed ID: 15127320
[TBL] [Abstract][Full Text] [Related]
17. [The role of the system of hemostasis in the development of vascular lesions in diabetes mellitus].
Lapotnikov VA; Moiseev SI
Ter Arkh; 1988; 60(9):31-5. PubMed ID: 3217876
[TBL] [Abstract][Full Text] [Related]
18. A study on the action of vitamin E supplementation on plasminogen activator inhibitor type 1 and platelet nitric oxide production in type 2 diabetic patients.
Vignini A; Nanetti L; Moroni C; Testa R; Sirolla C; Marra M; Manfrini S; Fumelli D; Marcheselli F; Mazzanti L; Rabini RA
Nutr Metab Cardiovasc Dis; 2008 Jan; 18(1):15-22. PubMed ID: 17949955
[TBL] [Abstract][Full Text] [Related]
19. [Plasma, erythrocyte and platelet magnesium in essential hyperTension, diabetes mellitus without and with macrovascular complications and atherosclerotic vascular disease].
Grifò G; Lo Presti R; Montana M; Canino B; Caimi G
Recenti Prog Med; 1995 Nov; 86(11):431-6. PubMed ID: 8539474
[TBL] [Abstract][Full Text] [Related]
20. Plasminogen activator inhibitor-1 activity in type 2 diabetes: a different relationship with coronary heart disease and diabetic retinopathy.
Brazionis L; Rowley K; Jenkins A; Itsiopoulos C; O'Dea K
Arterioscler Thromb Vasc Biol; 2008 Apr; 28(4):786-91. PubMed ID: 18239151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
